関連する実験動画
Updated: Jul 15, 2026

14:19
Primary Outcome Assessment in a Pig Model of Acute Myocardial Infarction
Published on: October 14, 2016
エフェキシリンマレアートの影響は,イシュミックな犬の心筋動脈における冠動脈の流れ分布に起因する
Circulation
|July 1, 1976
まとめ
ペルヘキシリンマレアートは,静脈内投与で,冠動脈の血流を改善し,犬の心筋の酸素消費を減少させた. この薬は,イシュケミアによる左心房不全の値を変更しませんでした.
科学分野:
- 心血管薬理学について
- 心筋の代謝について
- 発血性心臓病 発血性心臓病 発血性心臓病 発血性心臓病とは
背景:
- 冠動脈疾患は依然として死亡の主な原因である.
- 新薬学的薬剤が心筋機能に与える影響を理解することは,新しい治療法の開発に不可欠です.
- ペルヘクシリンマレアートは,抗痛特性がある薬剤です.
研究 の 目的:
- 犬のモデルで冠動脈の血液動力学と心筋の代謝に対する静脈内ペルキシリンマレートの影響を調査する.
- 固定冠動脈の流れの条件下において,ケフェキシリンマレー酸が内臓の血流を維持できるかどうかを判断する.
- 血栓不全に起因する左心房不全の値に対するペアキシリンマレートの影響を評価する.
主な方法:
- 犬のモデルにおいて,ペレキシリンマレアートの静脈内投与.
- 冠動脈のダイアストリック圧力と冠動脈の血流の測定.
- 心筋の酸素消費と乳酸吸収の評価.
- 発血性左心房不全の値の評価.
主要な成果:
- ペルヘキシリンマレアートは冠動脈のダイアストリック圧力を増加させた.
- この薬は冠動脈の血流を効果的に再分配し,心臓内循環の流れを保ちました.
- 心筋の酸素消費量が著しく減少しました.
- 乳酸の吸収は,perhexiline maleateによって強化されました.
- 発作による左心房不全の値に有意な影響は見られなかった.
結論:
- 静脈内投与のペルキシリンマレアートは,犬のモデルで冠動脈の血液動力学と心筋の代謝に有益な効果を示しています.
- 薬物の内臓の流れを保ち,酸素の需要を減らす能力は,心不全性疾患における潜在的な治療価値を示唆しています.
- 冠動脈疾患を患っている患者における perhexiline maleateの臨床有効性を調べるためにさらなる研究が必要である.
関連する概念動画
Heart Failure Drugs: Inotropic Agents
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Heart Failure Drugs: β-Blockers
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
Imbalances in Cardiac Output
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...

